Biomarkers /
ERCC1
Overview
Excision repair cross-complementation group 1 (ERCC1) is a gene that encodes a protein that functions in the nucleotide excision repair pathway. Missense mutations, silent mutations, and nonsense mutations are observed in cancers such as endometrial cancer, skin cancer, and colon cancer.
Clinical Trials
Significance of ERCC1 in Diseases
References
1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta
2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.
3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.
4. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.